Longboard Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-	14,175	-1,030	11,828	-6,475	-20,577
Depreciation & Amortization	-	6,515	3,066	1,514	1,282	1,229
Other Amortization	-	-	2.1	0.3	0.1	0.9
Loss (Gain) From Sale of Assets	-	-61.9	-137.8	-535.4	-346	-611.8
Loss (Gain) From Sale of Investments	-	-249.5	-46	-32.9	440.8	264.6
Loss (Gain) on Equity Investments	-	1,335	1,549	-7,415	-2,462	2,866
Provision & Write-off of Bad Debts	-	-	193.1	57	242.8	198
Other Operating Activities	-	29,660	6,519	-3,395	9,746	19,960
Change in Accounts Payable	-	-15,637	1,193	2,875	5,303	1,150
Change in Other Net Operating Assets	-	-5,554	5,757	7,725	4,416	1,402
Operating Cash Flow	-	28,327	16,903	12,303	12,146	5,881
Operating Cash Flow Growth	-	67.59%	37.38%	1.29%	106.54%	-
Capital Expenditures	-	-2,703	-986.3	-244.9	-1,517	-1,129
Sale of Property, Plant & Equipment	-	1,797	589.3	951.7	2,018	1,235
Cash Acquisitions	-	-	-1,736	-	-	-
Investment in Securities	-	-3,293	-8,167	26,645	-820.7	12,123
Other Investing Activities	-	2,071	1,164	9,539	11,249	4,340
Investing Cash Flow	-	-1,591	-9,026	30,938	12,667	6,916
Short-Term Debt Issued	-	561.5	-	4,075	-	479.6
Long-Term Debt Issued	-	10,406	27,543	11,263	13,602	51,427
Total Debt Issued	-	10,967	27,543	15,338	13,602	51,906
Short-Term Debt Repaid	-	-	-1,041	-	-3,277	-
Long-Term Debt Repaid	-	-26,307	-29,492	-42,880	-20,253	-52,272
Total Debt Repaid	-	-26,307	-30,533	-42,880	-23,530	-52,272
Net Debt Issued (Repaid)	-	-15,340	-2,989	-27,543	-9,927	-366.1
Other Financing Activities	-	-8,833	-10,248	-10,854	-12,204	-15,664
Financing Cash Flow	-	-24,173	-13,237	-38,397	-22,131	-16,030
Foreign Exchange Rate Adjustments	-	24	8.4	259.3	7.4	8.5
Net Cash Flow	-	2,587	-5,352	5,103	2,690	-3,225
Free Cash Flow	-	25,624	15,917	12,058	10,629	4,752
Free Cash Flow Growth	-	60.99%	32.00%	13.44%	123.66%	-
Free Cash Flow Margin	-	40.39%	35.46%	21.86%	25.91%	17.39%
Free Cash Flow Per Share	-	37.45	26.37	19.98	17.61	7.87
Cash Interest Paid	-	8,833	10,248	10,854	12,204	15,664
Cash Income Tax Paid	-	21.7	45.7	936.9	918.7	32.7
Levered Free Cash Flow	-	-34,704	2,679	-6,857	-2,194	-
Unlevered Free Cash Flow	-	-24,886	11,213	749.49	6,080	-
Change in Net Working Capital	-	35,468	-4,013	2,624	-3,739	-

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.